Stacy Wu

Stacy Wu, MD, currently serves as Vice President, Head of Clinical Research Biopharma at Sumitomo Pharma America, Inc., overseeing early and late-stage clinical development across various therapeutic areas, including CNS, rare diseases, women's health, urology, and cell therapies since March 2020. Prior to this role, Stacy Wu held multiple leadership positions in clinical research at Sunovion Pharmaceuticals and Otsuka Pharmaceutical Companies, focusing on neurology and CNS development. With a solid foundation in clinical practice as a Clinical Research Fellow in Multiple Sclerosis at University Hospital Basel and clinical fellowships at Columbia University Medical Center, Stacy Wu also brings valuable experience from Novartis and early training at St. Luke's-Roosevelt Hospital. Stacy Wu earned a Bachelor's degree from Brown University and an MD from NYU Grossman School of Medicine.